CINECA IRIS Institutional Research Information System

BEZZERRI, VALENTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.522
NA - Nord America 783
SA - Sud America 466
EU - Europa 411
Continente sconosciuto - Info sul continente non disponibili 96
AF - Africa 34
OC - Oceania 3
Totale 3.315
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 739
SG - Singapore 488
BR - Brasile 340
CN - Cina 246
VN - Vietnam 237
HK - Hong Kong 222
KR - Corea 178
DE - Germania 141
IT - Italia 102
BD - Bangladesh 50
AR - Argentina 46
FR - Francia 46
EC - Ecuador 25
ID - Indonesia 25
CO - Colombia 21
PL - Polonia 19
CA - Canada 17
UA - Ucraina 16
IN - India 14
NL - Olanda 12
MX - Messico 11
PY - Paraguay 11
RU - Federazione Russa 11
MA - Marocco 10
ZA - Sudafrica 10
ES - Italia 9
GB - Regno Unito 9
PE - Perù 9
CL - Cile 8
AT - Austria 7
FI - Finlandia 7
IQ - Iraq 7
JP - Giappone 7
AE - Emirati Arabi Uniti 6
SA - Arabia Saudita 6
LV - Lettonia 5
EG - Egitto 4
LT - Lituania 4
PK - Pakistan 4
TH - Thailandia 4
UZ - Uzbekistan 4
VE - Venezuela 4
BG - Bulgaria 3
CH - Svizzera 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
SE - Svezia 3
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
CR - Costa Rica 2
ET - Etiopia 2
GR - Grecia 2
IE - Irlanda 2
LK - Sri Lanka 2
QA - Qatar 2
RO - Romania 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
TR - Turchia 2
AG - Antigua e Barbuda 1
AU - Australia 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
ML - Mali 1
NI - Nicaragua 1
NO - Norvegia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
UY - Uruguay 1
Totale 3.219
Salva come PNG Salva come JPEG
Città #
Hong Kong 222
Singapore 205
Seoul 163
West Jordan 110
Ashburn 103
Frankfurt am Main 98
Ho Chi Minh City 86
Chicago 83
San Jose 78
Guangzhou 57
Hanoi 54
Beijing 43
São Paulo 33
New York 31
Munich 27
Boardman 22
Hillsboro 17
Warsaw 17
Sona 16
Jeju City 15
Los Angeles 15
Haiphong 13
Guayaquil 11
Da Nang 10
Seattle 9
Dallas 8
Quito 8
Rio de Janeiro 8
Brasília 7
Campinas 7
Phoenix 7
Amsterdam 6
Milan 6
Montreal 6
Newark 6
Nuremberg 6
Rome 6
Santa Clara 6
Surabaya 6
Thái Bình 6
Tokyo 6
Baghdad 5
Biên Hòa 5
Bogotá 5
Chennai 5
Dhaka 5
Dubai 5
Ferrara 5
Limburg an der Lahn 5
Ninh Bình 5
Quilmes 5
Reston 5
Ribeirão Preto 5
Riga 5
Bauru 4
Belo Horizonte 4
Brooklyn 4
Buffalo 4
Casablanca 4
Charlotte 4
Curitiba 4
Denver 4
Fortaleza 4
Johannesburg 4
Lima 4
Manaus 4
Medellín 4
Padua 4
Salvador 4
San Francisco 4
Tashkent 4
Turku 4
Atlanta 3
Belém 3
Bắc Ninh 3
Córdoba 3
Formosa 3
Guarulhos 3
Ha Long 3
Helsinki 3
Huế 3
Ipatinga 3
Mauá 3
Mendoza 3
Modena 3
Nairobi 3
Palermo 3
Paris 3
Ponta Grossa 3
Ponte San Pietro 3
Riyadh 3
Santo André 3
Stockholm 3
Tel Aviv 3
Thái Nguyên 3
Turin 3
Tây Ninh 3
Vienna 3
Zurich 3
'Asir Region 2
Totale 1.863
Salva come PNG Salva come JPEG
Nome #
Differential Effects of Angelicin Analogues on NF-κB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 74
Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives 67
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 64
Effect of beta-Sitosterol in pro-inflammatory gene expression in bronchial epithelial cells 59
EFFETTO ANTI-INFIAMMATORIO DI TRIMETIL-ANGELICINA SU CELLULE DELL'EPITELIO BRONCHIALE 58
Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: Inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa 56
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients 54
Effetto anti-infiammatorio del miglustat su cellule dell'epitelio bronchiale 50
LACK OF EFFICACY OF DEXAMETHASONE IN REDUCING THE INFLAMMATORY RESPONSE TO P. AERUGINOSA IN A CELL LINE DERIVED FROM BRONCHIAL EPITHELIUM OF A CF PATIENT 49
Anti-inflammatory effect of miglustat in bronchial epithelial cells 49
A Signature of Differentially Expressed Micrornas in Lymphoblastoid Cells from Shwachman-Diamond Syndrome Patients Indicates Possible Molecular Targets for Mirna Therapeutics 49
Transient receptor potential ankyrin 1 channels modulate inflammatory response in respiratory cells from patients with cystic fibrosis 49
β-Sitosterol reduces the expression of chemotactic cytokine genes in cystic fibrosis bronchial epithelial cells 48
Growth Charts for Shwachman–Diamond Syndrome at Ages 0 to 18 Years 48
BETA-SITOSTEROL, IDENTIFIED FROM NIGELLA ARVENSIS, INHIBITS THE INDUCTION OF IL-8 GENE IN BRONCHIAL EPITHELIAL CELLS 47
COMBINED EFFECTS OF FUROCOUMARIN COMPOUNDS AS ANTI-INFLAMMATORY AND CFTR POTENTIATOR IN CALU-3 EPITHELIAL CELLS 47
Elexacaftor/Tezacaftor/Ivacaftor Efficacy in a Cohort of Italian Patients with CFTR Rare Mutations 47
NIGELLA ARVENSIS EXTRACT INHIBITS THE INDUCTION OF IL-8 GENE IN BRONCHIAL EPITHELIAL CELLS 46
Medicinal plant extracts inhibit the induction of pro-inflammatory genes in bronchial epithelial cells 45
Antioxidants As a Novel Treatment to Revert Impaired Angiogenic Potential Driven By Metabolic Alterations Observed in Shwachman-Diamond Syndrome Derived Mesenchymal Stromal Cells 44
Deletion of eif6 Partially Rescues Survival, but Not Neutropenia, of Zebrafish Model of Shwachman-Diamond Syndrome: The Roles of Sbds and Eif6 in Perturbing Lipid Metabolism 42
Nonsense suppression therapy: New hypothesis for the treatment of inherited bone marrow failure syndromes 42
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 41
ANTI-INFLAMMATORY MOLECULES OBTAINED FROM VIRTUAL SCREENING OF A FUROCOUMARIN DATABASE AGAINST NF-KB 41
ANTI-INFLAMMATORY EFFECT OF MIGLUSTAT: SPHINGOLIPID METABOLISM AS A THERAPEUTIC TARGET FOR CF LUNG INFLAMMATION 40
Silencing of genes coding for transcription factors: Biological effects of decoy oligonucleotides on cystic fibrosis bronchial epithelial cells 40
Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis 40
The Molecular and Genetic Mechanisms of Inherited Bone Marrow Failure Syndromes: The Role of Inflammatory Cytokines in Their Pathogenesis 40
DOWN-MODULATION OF NEUTROPHIL CHEMOTACTIC SIGNALLING BY TARGETING THE METABOLISM OF SPHINGOLIPIDS 40
Method of treatment of shwachman-diamond syndrome 40
Cystic fibrosis: New therapeutic horizons 39
Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells 39
Virtual screening against p50 NF-κB transcription factor for the identification of inhibitors of the NF-κB-DNA interaction and expression of NF-κB upregulated genes 39
PLCB3 in pro-inflammatory signaling in bronchial epithelial cells 39
Further insights into the hematological disorders observed in Shwachman-Diamond syndrome: mTOR and STAT3 hyper-phosphorylation in CD4+ and CD8+ T cells and efficacy of rapamycin treatment 39
INVOLVEMENT OF THE CAAT/ENHANCER BINDING PROTEIN HOMOLOGOUS TRANSCRIPTION FACTOR (CHOP) IN P-AERUGINOSA-DEPENDENT IL-8 TRANSCRIPTION 39
TRIMETHYLANGELICIN MODULATES NEUTROPHIL CHEMOTAXIS IN MURINE MODEL OF PSEUDOMONAS AERUGINOSA ACUTE LUNG INFECTION 39
Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis 39
Expression of microRNA-93 and interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses 39
Is cellular senescence involved in cystic fibrosis? 38
Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: Correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expression 37
Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function 37
Modulation of expression of genes involved in leukocyte chemotaxis by interfering with nuclear transcription factors 37
Does cystic fibrosis constitute an advantage in COVID-19 infection? 37
Shwachman-Diamond syndromes: clinical, genetic, and biochemical insights from the rare variants 37
MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells 37
Cystic fibrosis: New therapeutic horizons [Fibrosi cistica: I nuovi orizzonti terapeutici] 37
Counteracting the Common Shwachman–Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing 37
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: Hyper-activation of mTOR and STAT3 in leukocytes 36
Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen 36
COVID-19 disease in patients with chronic neutropenia: The experience from the European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias 36
Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Sp1 superfamily 36
Cystic fibrosis: New therapeutic horizons 35
Transcription factor oligodeoxynucleotides to NF-kappa B inhibit transcription of IL-8 in bronchial cells 34
Enhanced P53 levels are involved in the reduced mineralization capacity of osteoblasts derived from shwachman–diamond syndrome subjects 34
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221 34
Miglustat and DGJ reduce the inflammatory response to pseudomonas aeruginosa, TNF-alpha and IL-1beta in bronchial epithelial cells 34
MTOR and STAT3 pathway hyper-activation is associated with elevated interleukin-6 levels in patients with shwachman-diamond syndrome: Further evidence of lymphoid lineage impairment 33
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman–Diamond syndrome cells 33
Phospholipase C-β3 is a key modulator of IL-8 expression in cystic fibrosis bronchial epithelial cells 33
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 33
Effects of decoy molecules targeting NFkappaB transcription factors in Cystic fibrosis IB3-1 cells: Recruitment of NFkappaB to the IL-8 gene promoter and transcription of the IL-8 gene 33
Ataluren-driven restoration of Shwachman-Bodian-Diamond syndrome protein function in Shwachman-Diamond syndrome bone marrow cells 33
Novel Translational Read-Through–Inducing Drugs as A Therapeutic Option for Shwachman-Diamond Syndrome 32
Study of Angiogenic Potential and Oxidative Metabolism in Mesenchymal Stromal Cells Derived from Shwachman-Diamond Syndrome Patients 32
PLCB3 cooperates with the Toll-like receptors' signaling cascade enhancing P.aeruginosa-dependent IL-8 expression in bronchial epithelial cells 31
The pathogenic variant c.258+533_459+403del in SBDS gene is the commonest rare variant in Italy and shows a founder effect 31
Transcription factor oligodeoxynucleotides to NF-κB inhibit transcription of IL-8 in bronchial cells 31
Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells 31
Modulators of sphingolipid metabolism reduce lung inflammation 30
PLCB3 loss of function reduces Pseudomonas aeruginosa-dependent IL-8 release in cystic fibrosis 30
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 29
Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells 29
Late generation lentiviral vectors: Evaluation of inflammatory potential in human airway epithelial cells 29
Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells 28
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 28
GBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa 28
Targeting transcription factor activity as a strategy to inhibit pro-inflammatory genes involved in cystic fibrosis: Decoy oligonucleotides and low-molecular weight compounds 28
Pharmacological modulators of sphingolipid metabolism for the treatment of cystic fibrosis lung inflammation 27
Pseudomonas aeruginosa reduces the expression of CFTR via post-translational modification of NHERF1 26
Beyond the bench: Revitalizing ataluren development for rare genetic disorders 24
Reduced EIF6 dosage attenuates TP53 activation in models of Shwachman-Diamond syndrome 24
A Focus on Inflammatory and Bacterial Biomarkers in Secondary Peritonitis 23
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation 20
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman–Diamond syndrome 19
Ataluren Treatment Improves Hematopoietic and Pancreatic Disorders in Patients with Shwachman-Diamond Syndrome 18
Effects of GM1 ganglioside and its derivatives on ETI-rescued F508del-CFTR maturation and host-pathogen interactions in cystic fibrosis bronchial cells 13
Reported Adverse Events in Patients with CF Receiving Treatment with Elexacaftor/Tezacaftor/Ivacaftor: 5 Years Observational Study 11
Beyond readthrough: ataluren restores mitochondrial function and reduces oxidative stress in FANCA-mutated cells via mTOR–DRP1 modulation 4
Modulation of immune responses by elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis: data from a compassionate use program 2
Development of translational read-through-inducing drugs as novel therapeutic options for patients with Fanconi anemia 2
The Molecular Landscape of Inflammation in Inflammatory Bowel Disease (IBD): Targets for Precision Medicine 1
Totale 3.315
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024260 0 0 0 0 0 0 0 0 58 113 66 23
2024/2025894 23 60 10 21 58 200 81 1 114 72 150 104
2025/20262.092 142 155 373 437 210 45 44 199 172 198 74 43
2026/202769 28 41 0 0 0 0 0 0 0 0 0 0
Totale 3.315